CD109 (Cluster of Differentiation 109) is a human gene.[5]

CD109
Identifiers
AliasesCD109, CPAMD7, p180, r150, CD109 molecule
External IDsOMIM: 608859; MGI: 2445221; HomoloGene: 25183; GeneCards: CD109; OMA:CD109 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001159587
NM_001159588
NM_133493

NM_153098

RefSeq (protein)

NP_001153059
NP_001153060
NP_598000

NP_694738

Location (UCSC)Chr 6: 73.7 – 73.83 MbChr 9: 78.52 – 78.62 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

CD109 is a GPI-linked cell surface antigen expressed by CD34+ acute myeloid leukemia cell lines, T-cell lines, activated T lymphoblasts, endothelial cells, and activated platelets (Lin et al., 2002). In addition, the platelet-specific Gov antigen system (HPA15),[6] implicated in refractoriness to platelet transfusion, neonatal alloimmune thrombocytopenia, and posttransfusion purpura, is carried by CD109 (Kelton et al., 1990; Lin et al., 2002).[supplied by OMIM][5]

See also

edit

References

edit
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000156535Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000046186Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: CD109 CD109 molecule".
  6. ^ "IPD - HPA Sequence Database| EBI".

Further reading

edit
edit